Abstract
Interstitial lung fibrosis is a term used to generally descibe wide group of disorders with different etiology, treatment possibilities and prognosis. In the cases, where any of either patients internal diseases or medication may lead to lung involvement, new manifestation or worsening of preexisting dyspnoea should lead to lung investigation.
Because diagnosis establishment and treatment is quite specific in patients with interstitial lung disorders, they should be concentrated into specialized centers. Past treatment modalities were based mainly on systemic corticosteroids.
Recently new treatment possibilities including biologics have emerged and could dramaticaly change the grim prognosis of before all of patients with idiopathic pulmonary fibrosis